Oncolytic virus CF33-hNIS monotherapy for the treatment of gastrointestinal (GI) malignancies.Daneng Li, Grey Wilkinson, Oscar Colunga Flores et al.|Journal of Clinical Oncology|2024Cited by 2
730 A phase I safety and tolerability study of VAXinia (CF33-hNIS), a novel chimeric oncolytic poxvirus, administered intratumorally or intravenously in adults with metastatic or advanced solid tumorsDaneng Li, Giovanni Selvaggi, Alexander I. Spira et al.|Regular and Young Investigator Award Abstracts|2023Cited by 0
Abstract CT182: Oncolytic virus CF33-hNIS for the treatment of advanced cancerDaneng Li, Jennifer L. Leddon, Anthony F. Shields et al.|Cancer Research|2024Cited by 0